MEI Pharma Inc

NASDAQ:MEIP  
2.69
-0.11 (-3.93%)
Earnings Announcements

MEI Pharma Reports Fiscal Year 2021 Results And Operational Highlights

Published: 09/02/2021 21:05 GMT
MEI Pharma Inc (MEIP) - Mei Pharma Reports Fiscal Year 2021 Results and Operational Highlights.
Mei Pharma Inc - Begins Fiscal Year 2022 With $153 Million in Cash.
Revenue is expected to be $10.56 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $5.36 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.